IOP-lowering therapy and ocular surface in glaucoma. Part 2. The effect of preservatives on ocular surface

<p> <b>IOP-lowering therapy and ocular surface in glaucoma. <br> Part 2. The effect of preservatives on ocular surface</b> </p> <p> <b>A.V.&nbsp;Antonova<sup>1</sup>, V.P.&nbsp;Nikolaenko<sup>1,2</sup>, V.V.&nbsp;Brzhe...

Full description

Saved in:
Bibliographic Details
Main Authors: A.V. Antonova, V.P. Nikolaenko, V.V. Brzheskiy
Format: Article
Language:Russian
Published: Prime-Media 2020-08-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/d7f/d7f8fecce68769701a1904c6d90d5a50.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526847575162880
author A.V. Antonova
V.P. Nikolaenko
V.V. Brzheskiy
author_facet A.V. Antonova
V.P. Nikolaenko
V.V. Brzheskiy
author_sort A.V. Antonova
collection DOAJ
description <p> <b>IOP-lowering therapy and ocular surface in glaucoma. <br> Part 2. The effect of preservatives on ocular surface</b> </p> <p> <b>A.V.&nbsp;Antonova<sup>1</sup>, V.P.&nbsp;Nikolaenko<sup>1,2</sup>, V.V.&nbsp;Brzheskiy<sup>3</sup></b> </p> <p> <b><sup>1</sup>City Multidisciplinary Hospital No. 2, St. Petersburg, Russian Federation</b> </p> <p> <b><sup>2</sup>St. Petersburg State University, St. Petersburg, Russian Federation</b> </p> <p> <b><sup>3</sup>St. Petersburg State Pediatric Medical University, St. Petersburg, Russian Federation</b> </p> <p> <i>This article reviews published data from different years (mainly recent data) on the effect of active ingredients and preservatives of IOP-lowering medications on ocular surface. The rate and severity of ocular surface diseases are directly associated with dosage regimen and duration of topical glaucoma treatment. Dose-dependent and time-dependent loss of goblet cells, expansion and activation of fibroblast populations, release of proinflammatory cytokines by conjunctival cells account for dry eye symptoms and signs, poor adherence to treatment, and poor results of glaucoma filtration surgery.</i> </p> <p> <i>However, the analysis of more than 16,000 PubMed publications using keywords “ocular surface” did not answer a number of important questions. Can ocular surface disease symptoms reduce following the surgery? Can ocular surface get back to its baseline anatomical functional state and provide long-term filtering bleb functioning? What is the maximum d uration of glaucoma pharmacotherapy to have a chance of ocular surface improvement after glaucoma surgery? The aim of our studies is to address these challenges.</i> </p> <p> <i><b>Keywords: </b>glaucoma, glaucoma therapy, ocular surface, dry eye disease, OSDI, inflammation, preservatives, benzalkonium chloride, preservative-free agents.</i> </p> <p> <i><b>For citation: </b>Antonova A.V., Nikolaenko V.P., Brzheskiy V.V. IOP-lowering therapy and ocular surface in glaucoma.&nbsp; Part 2. The effect of preservatives on ocular surface. Russian Journal of Clinical Ophthalmology. 2020;20(3):133–141. DOI: 10.32364/2311-7729-2020-20-3-133-141.</i> </p> <i><br> </i><br>
format Article
id doaj-art-f742965950234bcba86db59e316f2f60
institution Kabale University
issn 2311-7729
2619-1571
language Russian
publishDate 2020-08-01
publisher Prime-Media
record_format Article
series РМЖ "Клиническая офтальмология"
spelling doaj-art-f742965950234bcba86db59e316f2f602025-01-16T09:39:39ZrusPrime-MediaРМЖ "Клиническая офтальмология"2311-77292619-15712020-08-0120331132IOP-lowering therapy and ocular surface in glaucoma. Part 2. The effect of preservatives on ocular surfaceA.V. Antonova0V.P. Nikolaenko1V.V. Brzheskiy2Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<p> <b>IOP-lowering therapy and ocular surface in glaucoma. <br> Part 2. The effect of preservatives on ocular surface</b> </p> <p> <b>A.V.&nbsp;Antonova<sup>1</sup>, V.P.&nbsp;Nikolaenko<sup>1,2</sup>, V.V.&nbsp;Brzheskiy<sup>3</sup></b> </p> <p> <b><sup>1</sup>City Multidisciplinary Hospital No. 2, St. Petersburg, Russian Federation</b> </p> <p> <b><sup>2</sup>St. Petersburg State University, St. Petersburg, Russian Federation</b> </p> <p> <b><sup>3</sup>St. Petersburg State Pediatric Medical University, St. Petersburg, Russian Federation</b> </p> <p> <i>This article reviews published data from different years (mainly recent data) on the effect of active ingredients and preservatives of IOP-lowering medications on ocular surface. The rate and severity of ocular surface diseases are directly associated with dosage regimen and duration of topical glaucoma treatment. Dose-dependent and time-dependent loss of goblet cells, expansion and activation of fibroblast populations, release of proinflammatory cytokines by conjunctival cells account for dry eye symptoms and signs, poor adherence to treatment, and poor results of glaucoma filtration surgery.</i> </p> <p> <i>However, the analysis of more than 16,000 PubMed publications using keywords “ocular surface” did not answer a number of important questions. Can ocular surface disease symptoms reduce following the surgery? Can ocular surface get back to its baseline anatomical functional state and provide long-term filtering bleb functioning? What is the maximum d uration of glaucoma pharmacotherapy to have a chance of ocular surface improvement after glaucoma surgery? The aim of our studies is to address these challenges.</i> </p> <p> <i><b>Keywords: </b>glaucoma, glaucoma therapy, ocular surface, dry eye disease, OSDI, inflammation, preservatives, benzalkonium chloride, preservative-free agents.</i> </p> <p> <i><b>For citation: </b>Antonova A.V., Nikolaenko V.P., Brzheskiy V.V. IOP-lowering therapy and ocular surface in glaucoma.&nbsp; Part 2. The effect of preservatives on ocular surface. Russian Journal of Clinical Ophthalmology. 2020;20(3):133–141. DOI: 10.32364/2311-7729-2020-20-3-133-141.</i> </p> <i><br> </i><br>http://clinopht.com/upload/iblock/d7f/d7f8fecce68769701a1904c6d90d5a50.pdf
spellingShingle A.V. Antonova
V.P. Nikolaenko
V.V. Brzheskiy
IOP-lowering therapy and ocular surface in glaucoma. Part 2. The effect of preservatives on ocular surface
РМЖ "Клиническая офтальмология"
title IOP-lowering therapy and ocular surface in glaucoma. Part 2. The effect of preservatives on ocular surface
title_full IOP-lowering therapy and ocular surface in glaucoma. Part 2. The effect of preservatives on ocular surface
title_fullStr IOP-lowering therapy and ocular surface in glaucoma. Part 2. The effect of preservatives on ocular surface
title_full_unstemmed IOP-lowering therapy and ocular surface in glaucoma. Part 2. The effect of preservatives on ocular surface
title_short IOP-lowering therapy and ocular surface in glaucoma. Part 2. The effect of preservatives on ocular surface
title_sort iop lowering therapy and ocular surface in glaucoma part 2 the effect of preservatives on ocular surface
url http://clinopht.com/upload/iblock/d7f/d7f8fecce68769701a1904c6d90d5a50.pdf
work_keys_str_mv AT avantonova ioploweringtherapyandocularsurfaceinglaucomapart2theeffectofpreservativesonocularsurface
AT vpnikolaenko ioploweringtherapyandocularsurfaceinglaucomapart2theeffectofpreservativesonocularsurface
AT vvbrzheskiy ioploweringtherapyandocularsurfaceinglaucomapart2theeffectofpreservativesonocularsurface